Urogen Pharma (NASDAQ:URGN) Given Average Recommendation of "Moderate Buy" by Analysts
Urogen Pharma (NASDAQ:URGN - Get Free Report) has been given an average rating of "Moderate Buy" by the nine research firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and seven have given a buy rat...